Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
39.12
-0.96 (-2.40%)
Jul 30, 2026, 4:00 PM EDT - Market closed

Medline Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
29,14028,43225,50723,23121,448
Revenue Growth
12.07%11.47%9.80%8.31%-
Gross Profit
7,5357,5186,9765,8855,217
Operating Income
2,0632,2122,1461,250861
Net Income
1,0741,1591,200234-25
Earnings Per Share
1.27-0.01---
EPS Growth
-----

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Front Line Care
6,6106,5146,0885,8455,709
Surgical Solutions
6,3466,1665,4714,9314,446
Laboratory and Diagnostics
1,1061,040956837844
Supply Chain Solutions
15,14614,71212,99211,61810,449
Revenue (Total)
29,14028,43225,50723,23121,448

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Cash & Investments
2,2361,9391991,556
Total Debt
12,57212,56116,49416,517
Net Cash (Debt)
-10,336-10,622-16,295-14,961
Net Cash Growth
----
Net Cash Per Share
-12.22-13.11--

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
1,4741,7441,7691,685187
Capital Expenditures
-445-447-354-275-254
Free Cash Flow
1,0291,2971,4151,410-67
Free Cash Flow Growth
-32.17%-8.34%0.36%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
25.86%26.44%27.35%25.33%24.32%
Operating Margin
7.08%7.78%8.41%5.38%4.01%
Pretax Margin
4.12%4.39%4.88%1.14%0.05%
Profit Margin
3.69%4.07%4.70%1.01%-0.12%
FCF Margin
3.53%4.56%5.55%6.07%-0.31%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22
P/FCF Ratio
51.6026.29---
PS Ratio
1.761.20---